Brief: MaaT Pharma H1 Net Loss Widens To EUR 8.4 Million

Maat Pharma SA

26/09/2023 17:20

Sept 26 (Reuters) - Maat Pharma SA  MAAT.PA :
    * REVENUES OF EUR 1.4 MILLION IN H1 2023
    * AS OF JUNE 30, 2023, CASH AND CASH EQUIVALENTS WERE EUR
35.1
MILLION, ANTICIPATED CASH RUNWAY INTO Q2 2024
    * H1 NET LOSS EUR 8.4 MILLION VERSUS LOSS EUR 7.4 MILLION
YEAR AGO
    * H1 OPERATING LOSS EUR 8.5 MILLION VERSUS LOSS EUR 7.4
MILLION
YEAR AGO

Source text for Eikon:  ID:nBw4HB1Fxa 
Further company coverage:  MAAT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))